Christos Petridis

Breast Cancer Polygenic Risk Score Associated with Outcomes after In Situ Breast Disease.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: April 04, 2025

Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: June 17, 2020

Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.

Journal: American journal of human genetics

Published: May 15, 2020

A network analysis to identify mediators of germline-driven differences in breast cancer prognosis.

Journal: Nature communications

Published: January 31, 2019

Frequency of Pathogenic Germline Variants in CDH1, BRCA2, CHEK2, PALB2, BRCA1, and TP53 in Sporadic Lobular Breast Cancer.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: October 09, 2018

Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years.

Journal: Breast cancer research : BCR

Published: September 06, 2018

Tissue and Circulating MicroRNA Co-expression Analysis Shows Potential Involvement of miRNAs in the Pathobiology of Frontal Fibrosing Alopecia.

Journal: The Journal of investigative dermatology

Published: April 18, 2017

Breast Cancer Polygenic Risk Score Associated with Outcomes after In Situ Breast Disease.

Breast Cancer Polygenic Risk Score Associated with Outcomes after In Situ Breast Disease.

Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium.

Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium.

Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.

Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.

A network analysis to identify mediators of germline-driven differences in breast cancer prognosis.

A network analysis to identify mediators of germline-driven differences in breast cancer prognosis.

Frequency of Pathogenic Germline Variants in CDH1, BRCA2, CHEK2, PALB2, BRCA1, and TP53 in Sporadic Lobular Breast Cancer.

Frequency of Pathogenic Germline Variants in CDH1, BRCA2, CHEK2, PALB2, BRCA1, and TP53 in Sporadic Lobular Breast Cancer.

Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years.

Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years.

Genome-wide association study of germline variants and breast cancer-specific mortality.

Genome-wide association study of germline variants and breast cancer-specific mortality.

Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02.

Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02.

Genome-wide meta-analysis implicates mediators of hair follicle development and morphogenesis in risk for severe acne.

Genome-wide meta-analysis implicates mediators of hair follicle development and morphogenesis in risk for severe acne.

Tissue and Circulating MicroRNA Co-expression Analysis Shows Potential Involvement of miRNAs in the Pathobiology of Frontal Fibrosing Alopecia.

Tissue and Circulating MicroRNA Co-expression Analysis Shows Potential Involvement of miRNAs in the Pathobiology of Frontal Fibrosing Alopecia.

Non-syndromic severe hypodontia caused by a novel frameshift insertion mutation in the homeobox of the MSX1 gene.

Non-syndromic severe hypodontia caused by a novel frameshift insertion mutation in the homeobox of the MSX1 gene.

Genetic predisposition to ductal carcinoma in situ of the breast.

Genetic predisposition to ductal carcinoma in situ of the breast.